Predictive Presymptomatic Testing Market 2024-2028

Report
136 Pages
July 2024
Region: Global
TechNavio
ID: 5575479

The predictive presymptomatic testing market is forecasted to grow by USD 2.59 billion during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the predictive presymptomatic testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing healthcare spending worldwide, increasing demand for genetic counseling, and rise in awareness toward early screening of genetic disorders.

The predictive presymptomatic testing market is segmented as below:

By Application

Cancer diseases
Genetic diseases
Cardiovascular diseases

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing prevalence of genetic diseases as one of the prime reasons driving the predictive presymptomatic testing market growth during the next few years. Also, rise in awareness toward early screening of genetic disorders and advancements in genetic testing techniques will lead to sizable demand in the market.

The report on the predictive presymptomatic testing market covers the following areas:

Predictive presymptomatic testing market sizing
Predictive presymptomatic testing market forecast
Predictive presymptomatic testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading predictive presymptomatic testing market vendors that include 23andMe Holding Co., Abbott Laboratories, Amgen Inc., BioAxis DNA Research Centre P Ltd., Color Health Inc., Deep Genomics Inc., Direct Laboratory Services LLC, DNA and U, Editas Medicine Inc., Healius Ltd., Illumina Inc., International Business Machines Corp., Mapmygenome India Ltd., myDNA Life Ltd., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics Inc., Sysmex Corp., and Veritas Genetics Inc. Also, the predictive presymptomatic testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing

3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Predictive Presymptomatic Testing Market 2018 - 2022
Historic Market Size - Data Table on Global Predictive Presymptomatic Testing Market 2018 - 2022 ($ million)
4.2 Application segment analysis 2018 - 2022
Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
Chart on Application - Market share 2023-2028 (%)
Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
6.3 Cancer diseases - Market size and forecast 2023-2028
Chart on Cancer diseases - Market size and forecast 2023-2028 ($ million)
Data Table on Cancer diseases - Market size and forecast 2023-2028 ($ million)
Chart on Cancer diseases - Year-over-year growth 2023-2028 (%)
Data Table on Cancer diseases - Year-over-year growth 2023-2028 (%)
6.4 Genetic diseases - Market size and forecast 2023-2028
Chart on Genetic diseases - Market size and forecast 2023-2028 ($ million)
Data Table on Genetic diseases - Market size and forecast 2023-2028 ($ million)
Chart on Genetic diseases - Year-over-year growth 2023-2028 (%)
Data Table on Genetic diseases - Year-over-year growth 2023-2028 (%)
6.5 Cardiovascular diseases - Market size and forecast 2023-2028
Chart on Cardiovascular diseases - Market size and forecast 2023-2028 ($ million)
Data Table on Cardiovascular diseases - Market size and forecast 2023-2028 ($ million)
Chart on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
Data Table on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)

7 Customer Landscape

7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
8.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.11 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape

10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business

11 Competitive Analysis

11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
23andMe Holding Co.
23andMe Holding Co. - Overview
23andMe Holding Co. - Business segments
23andMe Holding Co. - Key offerings
23andMe Holding Co. - Segment focus
11.4 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
11.5 Color Health Inc.
Color Health Inc. - Overview
Color Health Inc. - Product / Service
Color Health Inc. - Key offerings
11.6 Direct Laboratory Services LLC
Direct Laboratory Services LLC - Overview
Direct Laboratory Services LLC - Product / Service
Direct Laboratory Services LLC - Key offerings
11.7 Healius Ltd.
Healius Ltd. - Overview
Healius Ltd. - Product / Service
Healius Ltd. - Key offerings
11.8 Mapmygenome India Ltd.
Mapmygenome India Ltd. - Overview
Mapmygenome India Ltd. - Product / Service
Mapmygenome India Ltd. - Key offerings
11.9 myDNA Life Ltd.
myDNA Life Ltd. - Overview
myDNA Life Ltd. - Product / Service
myDNA Life Ltd. - Key offerings
11.10 Myriad Genetics Inc.
Myriad Genetics Inc. - Overview
Myriad Genetics Inc. - Product / Service
Myriad Genetics Inc. - Key news
Myriad Genetics Inc. - Key offerings
11.11 Quest Diagnostics Inc.
Quest Diagnostics Inc. - Overview
Quest Diagnostics Inc. - Business segments
Quest Diagnostics Inc. - Key offerings
Quest Diagnostics Inc. - Segment focus
11.12 Sysmex Corp.
Sysmex Corp. - Overview
Sysmex Corp. - Business segments
Sysmex Corp. - Key offerings
Sysmex Corp. - Segment focus

12 Appendix

12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis

360 degree market analysis

12.10 List of abbreviations
List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Predictive Presymptomatic Testing Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Application - Market share 2023-2028 (%)
Exhibits 31: Data Table on Application - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Application
Exhibits 33: Data Table on Comparison by Application
Exhibits 34: Chart on Cancer diseases - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Cancer diseases - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Cancer diseases - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Cancer diseases - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Genetic diseases - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Genetic diseases - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Genetic diseases - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Genetic diseases - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Cardiovascular diseases - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Cardiovascular diseases - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Application ($ million)
Exhibits 47: Data Table on Market opportunity by Application ($ million)
Exhibits 48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 49: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 50: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 51: Chart on Geographic comparison
Exhibits 52: Data Table on Geographic comparison
Exhibits 53: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 89: Market opportunity By Geographical Landscape ($ million)
Exhibits 90: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 91: Impact of drivers and challenges in 2023 and 2028
Exhibits 92: Overview on criticality of inputs and factors of differentiation
Exhibits 93: Overview on factors of disruption
Exhibits 94: Impact of key risks on business
Exhibits 95: Companies covered
Exhibits 96: Matrix on companies position and classification
Exhibits 97: 23andMe Holding Co. - Overview
Exhibits 98: 23andMe Holding Co. - Business segments
Exhibits 99: 23andMe Holding Co. - Key offerings
Exhibits 100: 23andMe Holding Co. - Segment focus
Exhibits 101: Abbott Laboratories - Overview
Exhibits 102: Abbott Laboratories - Business segments
Exhibits 103: Abbott Laboratories - Key news
Exhibits 104: Abbott Laboratories - Key offerings
Exhibits 105: Abbott Laboratories - Segment focus
Exhibits 106: Color Health Inc. - Overview
Exhibits 107: Color Health Inc. - Product / Service
Exhibits 108: Color Health Inc. - Key offerings
Exhibits 109: Direct Laboratory Services LLC - Overview
Exhibits 110: Direct Laboratory Services LLC - Product / Service
Exhibits 111: Direct Laboratory Services LLC - Key offerings
Exhibits 112: Healius Ltd. - Overview
Exhibits 113: Healius Ltd. - Product / Service
Exhibits 114: Healius Ltd. - Key offerings
Exhibits 115: Mapmygenome India Ltd. - Overview
Exhibits 116: Mapmygenome India Ltd. - Product / Service
Exhibits 117: Mapmygenome India Ltd. - Key offerings
Exhibits 118: myDNA Life Ltd. - Overview
Exhibits 119: myDNA Life Ltd. - Product / Service
Exhibits 120: myDNA Life Ltd. - Key offerings
Exhibits 121: Myriad Genetics Inc. - Overview
Exhibits 122: Myriad Genetics Inc. - Product / Service
Exhibits 123: Myriad Genetics Inc. - Key news
Exhibits 124: Myriad Genetics Inc. - Key offerings
Exhibits 125: Quest Diagnostics Inc. - Overview
Exhibits 126: Quest Diagnostics Inc. - Business segments
Exhibits 127: Quest Diagnostics Inc. - Key offerings
Exhibits 128: Quest Diagnostics Inc. - Segment focus
Exhibits 129: Sysmex Corp. - Overview
Exhibits 130: Sysmex Corp. - Business segments
Exhibits 131: Sysmex Corp. - Key offerings
Exhibits 132: Sysmex Corp. - Segment focus
Exhibits 133: Inclusions checklist
Exhibits 134: Exclusions checklist
Exhibits 135: Currency conversion rates for US$
Exhibits 136: Research methodology
Exhibits 137: Information sources
Exhibits 138: Data validation
Exhibits 139: Validation techniques employed for market sizing
Exhibits 140: Data synthesis
Exhibits 141: 360 degree market analysis
Exhibits 142: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global predictive presymptomatic testing market: 23andMe Holding Co., Abbott Laboratories, Amgen Inc., BioAxis DNA Research Centre P Ltd., Color Health Inc., Deep Genomics Inc., Direct Laboratory Services LLC, DNA and U, Editas Medicine Inc., Healius Ltd., Illumina Inc., International Business Machines Corp., Mapmygenome India Ltd., myDNA Life Ltd., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics Inc., Sysmex Corp., and Veritas Genetics Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing prevalence of genetic diseases."

According to the report, one of the major drivers for this market is the increasing healthcare spending worldwide.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

23andMe Holding Co.
Abbott Laboratories
Amgen Inc.
BioAxis DNA Research Centre P Ltd.
Color Health Inc.
Deep Genomics Inc.
Direct Laboratory Services LLC
DNA and U
Editas Medicine Inc.
Healius Ltd.
Illumina Inc.
International Business Machines Corp.
Mapmygenome India Ltd.
myDNA Life Ltd.
Myriad Genetics Inc.
NeoGenomics Laboratories Inc.
Quest Diagnostics Inc.
Sysmex Corp.
Veritas Genetics Inc.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2443EUR$2,500USD£2,039GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3908EUR$4,000USD£3,263GBP

The predictive presymptomatic testing market is segmented as below:

By Application

By Geographical Landscape

The report on the predictive presymptomatic testing market covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Predictive and Presymptomatic Testing - Global Strategic Business Report

Direct-to-Consumer Genetic Testing Market 2024-2028

Nutrigenomics Market 2024-2028

Predictive Genetics Market by Type, Demographics, Test Type, Setting Type, Application - Global Forecast 2025-2030

Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides 2023 to 2027

About the Presymptomatic Testing Market